Goals: The aim of this study was to determine the antibiotic resistance profile of serotypes of Streptococcus pneumoniae strains circulating in Bangui. Methodology: A prospective and analytical analysis was carried out at the National Laboratory of Clinical Biology and Public Health from 2017 to 2022. The strains came from our study on the contribution to the study of antibiotic sensitivity of Streptococcus pneumoniae strains. The multiplex PCR test was used for its cost-effectiveness in terms of amplifiers which can be purified in order to be sequenced. It also makes it possible to detect several germs as well as their serotypes. For a PCR reaction, several elements are involved in the reaction medium or Master Mix. These are the desoxyribonucleotides (dNTPs), the magnesium ions (MgCl2) and the primers. A set of 14 primers divided into 3 classes were used. Class 1 primers served as an internal control by targeting the cpsA gene. It is a highly conserved gene found in capsular loci characterized to date. The primers of the second class were used to target specific serotypes by specific reactions (out of six possibilities). The group reaction was carried out using the primers of the third class in order to carry out an initial screening of the samples and to classify the pneumococcal isolates. Related serotypes were grouped based on the amplification of common genes. Using the technique of electrophoresis on agarose gel and an ultraviolet radiation device, the migration bands are then visualized and analyzed. The data collected had been entered into Excel 2010 and analyzed with Epi info 7. The exact Fischer chi2 test at the 5% threshold, the relative risk and its 95% confidence interval were used to compare the proportions and determine the associations. Results: 187 antibiotic-resistant strains of Streptococcus pneumoniae were collected. The average frequency of serotypes 1, 9A, 4 and untypeable identified were 43.59%, 18.18%, 18.27% and 39.57% respectively. The frequency of serotype 1 was predominant for the age group over five years old with 56.88%. The male sex was predominant with 55.08% for serotype 1. Resistance to penicillin and gentamicin for serotype 1 during this study, for the age group under 5 years old, was 77%. For serotypes 19A and 4, tetracycline resistance was predominant with 20% for the age group under 5 years. The resistance to penicillin and gentamicin of non-typeable serotypes was 33% for the age group under 5 years old. For the age group over 5 years
References
[1]
Troeger, C., Forouzanfar, M., Rao, P.C., Khalil, I., Brown, A., Swartz, S., et al. (2017) Estimates of the Global, Regional, and National Morbidity, Mortality, and Aetiologies of Lower Respiratory Tract Infections in 195 Countries: A Systematic Analysis for the Global Burden of Disease Study 2015. The Lancet Infectious Diseases, 17, 1133-1161. https://doi.org/10.1016/s1473-3099(17)30396-1
[2]
Razafindrakoto, C., Raboba, L., Harioly, N.M., Rahajamanana, L., Rakotomalala, A., Ra-koto, A.M., et al. (2014) Surveillance of Pediatric Bacterial Meningitis. Activity Report from the Charles Mérieux Infectiology Center.
[3]
College of Infectious Diseases (2010, June 30) Microbiology, Parasitology, Mycology. http://www.infectiologie.org
[4]
Brieu, A.N., Varon, E., Baraduc, R., et al. (2015) Regional Pneumococcus Observatories: Evolution of Antibiotic Resistance and Streptococcus pneumoniae Serotypes Isolated in France between 2009 and 2013. Journal of Anti-Infectious, 150, 146.
[5]
World Health Organization (2013) Handbook, Pediatric Hospital Care. Management of Common Childhood Conditions, 2nd Edition.
[6]
Song, J.Y., Nahm, M.H. and Moseley, M.A. (2013) Clinical Implications of Pneumococcal Serotypes: Invasive Disease Potential, Clinical Presentations, and Antibiotic Resistance. Journal of Korean Medical Science, 28, 4-15.
[7]
WHO (2007) Pneumococcal Vaconjugate Vaccines in Infants and Children under 5 Years of Age—Rec Position Paper 8212 93 104 17380597.
[8]
Isaacman, D.J., McIntosh, E.D. and Reinert, R.R. (2010) Burden of Invasive Pneumococcal Disease and Serotype Distribution among Streptococcus pneumoniae Isolates in Young Children in Europe: Impact of the 7-Valent Pneumococcal Conjugate Vaccine and Considerations for Future Conjugate Vaccines. International Journal of Infectious Diseases, 14, e197-e209. https://doi.org/10.1016/j.ijid.2009.05.010
[9]
Godot, C., Levy, C., Varon, E., Picard, C., Madhi, F. and Cohen, R. (2015) Pneumococcal Meningitis Vaccine Breakthroughs and Failures after Routine 7-Valent and 13-Valent Pneumococcal Conjugate Vaccination in Children in France. Pediatric Infectious Disease Journal, 34, e260-e263. https://doi.org/10.1097/inf.0000000000000818
[10]
Jaiswal, N., Singh, M., Das, R.R., Jindal, I., Agarwal, A., Thumburu, K.K., et al. (2014) Distribution of Serotypes, Vaccine Coverage, and Antimicrobial Susceptibility Pattern of Streptococcus pneumoniae in Children Living in Saarc Countries: A Systematic Review. PLOS ONE, 9, e108617. https://doi.org/10.1371/journal.pone.0108617
[11]
Weingarten, R.D., Markiewicz, Z. and Gilbert, D.N. (1990) Meningitis Due to Penicillin-Resistant Streptococcus pneumoniae in Adults. Clinical Infectious Diseases, 12, 118-124. https://doi.org/10.1093/clinids/12.1.118
[12]
Mendes, R.E., et al. (2014) Decreased Ceftriaxone Susceptibility in Emerging (35B and 6C) and Persisting (19A) Streptococcus pneumoniae Serotypes in the United States, 2011-2012: Ceftaroline Remains Active in Vitro among β-Lactam Agents. Antimicrobial Agents and Chemotherapy, 58, 4923-4927.
[13]
Goldblatt, D. (2017) The Indirect Effect of Pneumococcal Conjugate Vaccine. The Lancet Global Health, 5, e6-e7. https://doi.org/10.1016/s2214-109x(16)30338-2
[14]
Cabaj, J.L., Nettel-Aguirre, A., MacDonald, J., Vanderkooi, O.G. and Kellner, J.D. (2016) Influence of Childhood Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Adults with Underlying Comorbidities in Calgary, Alberta (2000-2013). Clinical Infectious Diseases, 62, 1521-1526. https://doi.org/10.1093/cid/ciw175
[15]
World Health Organization (2015) Weekly Epidemiological Record. http://www.who.int/wer
[16]
Reinert, R.R., Paradiso, P. and Fritzell, B. (2010) Advances in Pneumococcal Vaccines: The 13-Valent Pneumococcal Conjugate Vaccine Received Market Authorization in Europe. Vaccines, 9, 229-236. https://doi.org/10.1586/erv.10.6
[17]
Messaoudi, M., Milenkov, M., Albrich, W.C., van der Linden, M.P.G., Bénet, T., Chou, M., et al. (2016) The Relevance of a Novel Quantitative Assay to Detect up to 40 Major Streptococcus pneumoniae Serotypes Directly in Clinical Nasopharyngeal and Blood Specimens. PLOS ONE, 11, e0151428. https://doi.org/10.1371/journal.pone.0151428
[18]
Vogbia, Z., Lango Yaya, E., Colette-Nganda Banguet, M., de Dieu Longo, J., Rafaï, C., Ouoko Fa-Tigbia, M.A.A., et al. (2023) Contribution to the Study of Antibiotic Sensitivity of Streptococcus pneumoniae Strains in Spinal Cerebral Fluids in Bangui from 2017 to 2022. Journal of Biomedical Science and Engineering, 16, 95-106. https://doi.org/10.4236/jbise.2023.167007
[19]
Grando, I.M., Moraes, C.d., Flannery, B., Ramalho, W.M., Horta, M.A.P., Pinho, D.L.M., et al. (2015) Impact of 10-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis in Children up to Two Years of Age in Brazil. Cadernos de Saúde Pública, 31, 276-284. https://doi.org/10.1590/0102-311x00169913
[20]
Nhantumbo, A.A., Gudo, E.S., Caierão, J., Munguambe, A.M., Comé, C.E., Zimba, T.F., et al. (2016) Serotype Distribution and Antimicrobial Resistance of Streptococcus pneumoniae in Children with Acute Bacterial Meningitis in Mozambique: Implications for a National Immunization Strategy. BMC Microbiology, 16, Article No. 134. https://doi.org/10.1186/s12866-016-0747-y
[21]
Kwambana-Adams, B.A., Asiedu-Bekoe, F., Sarkodie, B., Afreh, O.K., Kuma, G.K., Owusu-Okyere, G., et al. (2016) An Outbreak of Pneumococcal Meningitis among Older Children (≥ 5 Years) and Adults after the Implementation of an Infant Vaccination Programme with the 13-Valent Pneumococcal Conjugate Vaccine in Ghana. BMC Infectious Diseases, 16, Article No. 575. https://doi.org/10.1186/s12879-016-1914-3
[22]
Kambiré, D., Soeters, H.M., Ouédraogo-Traoré, R., Medah, I., Sangare, L., Yaméogo, I., et al. (2016) Nationwide Trends in Bacterial Meningitis before the Introduction of 13-Valent Pneumococcal Conjugate Vaccine—Burkina Faso, 2011-2013. PLOS ONE, 11, e0166384. https://doi.org/10.1371/journal.pone.0166384
[23]
Demczuk, W.H.B., Martin, I., Griffith, A., Lefebvre, B., McGeer, A., Lovgren, M., et al. (2013) Serotype Distribution of Invasive Streptococcus pneumoniae in Canada after the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine, 2010-2012. Canadian Journal of Microbiology, 59, 778-788. https://doi.org/10.1139/cjm-2013-0614
[24]
Méndez-Lage, S., Losada-Castillo, I. and Agulla-Budiño, A. (2015) Streptococcus pneumoniae: Distribución de serotipos, sensibilidad antibiótica, factores de riesgo y mortalidad en Galicia en un periodo de 2 años. Enfermedades Infecciosas y Microbiología Clínica, 33, 579-584. https://doi.org/10.1016/j.eimc.2015.01.010
[25]
Hecini-Hannachi A. (2014) Streptococcus pneumoniae in Invasive Infections: Identification, Antibiotic Resistance and Serotyping University. Thesis, Constantine I Faculty of Natural and Life Sciences Department of Microbiology, Bacteriology, 269 p.
[26]
Kambiré, D., Soeters, H.M., Ouédraogo-Traoré, R., Medah, I., Sangaré, L., Yaméogo, I., et al. (2018) Early Impact of 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis—Burkina Faso, 2014-2015. Journal of Infection, 76, 270-279.
